Elutia Inc. SEC filings ELUT

Elutia Inc. has 369 filings in SEC EDGAR's recent list, going back to Jun 9, 2017. Its latest annual report, Form ARS, was filed on Apr 22, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 14, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Aug 21, 2026 (acquisition or sale of assets, regulation fd disclosure). The company's fiscal year ends on December 31.

Form Description Filed Period
DEFA14A Additional proxy material Apr 22, 2026 —
DEF 14A Proxy statement Apr 22, 2026 Jun 11, 2026
DEFA14A Additional proxy material Apr 4, 2025 —
DEF 14A Proxy statement Apr 4, 2025 May 29, 2025
DEFA14A Additional proxy material Apr 22, 2024 —
DEF 14A Proxy statement Apr 22, 2024 Jun 6, 2024
DEFA14A Additional proxy material Apr 27, 2023 —
DEF 14A Proxy statement Apr 27, 2023 Jun 8, 2023
DEFA14A Additional proxy material Apr 22, 2022 —
DEF 14A Proxy statement Apr 22, 2022 Jun 7, 2022
DEFA14A Additional proxy material Apr 23, 2021 —
DEF 14A Proxy statement Apr 23, 2021 Jun 7, 2021

Showing 12 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.

New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.

Company profile

Industry
Biological Products, (No Diagnostic Substances) (SIC 2836)
Listed as
ELUT (Nasdaq)
Fiscal year ends
December 31
Incorporated in
DE
Headquarters
Silver Spring, MD
SEC filer status
, Emerging growth company
SEC CIK
1708527
Former names
AZIYO BIOLOGICS, INC. (until Aug 14, 2023)

Other Biological Products, (No Diagnostic Substances) companies

All 182 Biological Products, (No Diagnostic Substances) companies

Source: SEC EDGAR filings. This is company-reported data, not investment advice.